Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$2.97 -0.10 (-3.15%)
As of: Oct 21, 2026 · 9:55 AM EDT

Galmed Pharmaceuticals (EOCN) Asset Utilization Ratio (2017 - 2023)

Updated

Galmed Pharmaceuticals' Asset Utilization Ratio came in at 0.02 for Q2 2019, up 4.8% from 0.02 a year earlier.

Analysis

Galmed Pharmaceuticals (EOCN) Asset Utilization Ratio (2017 - 2023) Analysis & Trends

For FY2018, Galmed Pharmaceuticals' Asset Utilization Ratio was 0.04, down 38.5% from FY2017.

  • Going back by year, Asset Utilization Ratio was 0.06 in FY2017 (+162.1%) and 0.02 in FY2016.
  • The five-year range for quarterly Asset Utilization Ratio is 0.02 (Q2 2018) to 0.11 (Q3 2017).
  • Year-over-year, Asset Utilization Ratio increased in two of the last four quarters, with an average decline of 32.8%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,139.37 Bn 1,107.95 Bn 19.71 Bn 0.62
2 Johnson & Johnson 618.39 Bn 536.92 Bn 17.26 Bn 0.49
3 AbbVie 508.07 Bn 481.19 Bn 12.70 Bn 0.47
4 Merck 367.07 Bn 321.44 Bn 12.21 Bn 0.52
5 Novartis Ag 298.65 Bn 262.64 Bn 11.24 Bn 0.46
6 Astrazeneca 263.08 Bn 236.77 Bn 12.86 Bn 0.51
7 Amgen 236.65 Bn 192.05 Bn 7.24 Bn 0.40
8 Gilead Sciences 192.73 Bn 166.92 Bn 6.22 Bn 0.58
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn 0.31
10 Galmed Pharmaceuticals 2.42 Mn -38.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 0.03
Mar 31, 2022 0.05
Jun 30, 2019 0.02
Dec 31, 2018 0.02
Sep 30, 2018 0.02
Jun 30, 2018 0.02
Mar 31, 2018 0.06
Dec 31, 2017 0.07
Sep 30, 2017 0.11
Jun 30, 2017 0.09
Mar 31, 2017 0.05
API Access

Galmed Pharmaceuticals Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=EOCN&period=max&api_key=YOUR_API_KEY